Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,610.00
Bid: 1,609.50
Ask: 1,610.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.031%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks at one-month high as Vodafone, RBS gain

Fri, 21st Feb 2014 08:47

- Vodafone, RBS and Glaxo provide a lift- IHG, Glencore Xstrata hit by downgrades- FTSE 100 at highest intraday level in monthtechMARK 2,891.98 +0.55%FTSE 100 6,840.31 +0.40%FTSE 250 16,419.58 +0.31% Strong gains from heavyweights Vodafone, RBS and GlaxoSmithKline gave UK markets a boost on Friday with stocks rising to levels not seen in a month.The FTSE 100 was trading 0.4% higher at 6,840 early on, its highest intraday level since January 22nd.A decent performance on Wall Street last night has helped to spur buying this morning, as US indices turned around after a poor start as data showed that manufacturing activity Stateside rose to a four-year high."I think this clearly highlights the fact that the market is still generally bullish and is once again looking for any excuse to buy," said Market Analyst Craig Erlam from Alpari.After a data-heavy week, today's session is set to be a little quieter on the macro front, though UK retail sales and public-sector borrowing figures will catch investors' attentions this morning.Vodafone, RBS and Glaxo provide a liftTelecoms titan Vodafone was making decent gains this morning with shareholders set to receive a windfall from the company's sale of its 45% stake in Verizon Wireless. The $130bn cash and shares deal is set to complete today.RBS was higher amid reports that the bank will announce plans to slash as many as 30,000 jobs, reducing its staff count to the lowest levels in more than 10 years.Pharmaceuticals giant GlaxoSmithKline was higher after European regulators recommended marketing authorisation for umeclidinium, its once-daily treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.Millennium & Copthorne, the FTSE 250 hotel firm, jumped after reporting record revenues and profits for 2013 as fourth-quarter results were boosted by the one-off sale of the bulk of the Glyndebourne development in Singapore.Sector peer InterContinental Hotels Group, however, was trading in the red after Credit Suisse lowered its recommendation to 'underperform', pointing out that the shares are trading within just 4% of their all-time high at a price-to-earnings ratio of 23.Glencore Xstrata was also lower after JPMorgan Cazenove downgraded its rating on the stock to 'neutral', saying that its peers have overtaken it in terms of capital returns potential.FTSE 100 - RisersVodafone Group (VOD) 236.00p +2.79%Royal Bank of Scotland Group (RBS) 361.70p +1.69%ARM Holdings (ARM) 962.50p +1.64%Persimmon (PSN) 1,459.00p +1.53%Prudential (PRU) 1,370.00p +1.11%Barclays (BARC) 258.05p +1.10%Aviva (AV.) 473.40p +1.09%BAE Systems (BA.) 404.70p +1.07%British Land Co (BLND) 702.50p +0.93%Compass Group (CPG) 925.50p +0.93%FTSE 100 - FallersGlencore Xstrata (GLEN) 333.05p -2.17%InterContinental Hotels Group (IHG) 1,934.00p -2.08%Smiths Group (SMIN) 1,366.00p -1.73%IMI (IMI) 1,544.00p -1.34%Mondi (MNDI) 1,032.00p -1.24%Anglo American (AAL) 1,536.50p -1.13%Morrison (Wm) Supermarkets (MRW) 239.50p -1.07%Fresnillo (FRES) 975.00p -1.02%easyJet (EZJ) 1,732.00p -0.92%Antofagasta (ANTO) 942.50p -0.84%FTSE 250 - RisersMillennium & Copthorne Hotels (MLC) 598.00p +4.64%Essentra (ESNT) 875.00p +3.55%IP Group (IPO) 221.00p +3.22%Petra Diamonds Ltd.(DI) (PDL) 170.10p +3.03%Centamin (DI) (CEY) 51.70p +2.48%Morgan Advanced Materials (MGAM) 341.40p +1.88%Laird (LRD) 328.30p +1.77%Informa (INF) 531.00p +1.72%Afren (AFR) 156.10p +1.63%AL Noor Hospitals Group (ANH) 917.50p +1.61%FTSE 250 - FallersVesuvius (VSVS) 462.70p -1.91%Telecity Group (TCY) 669.50p -1.69%Electra Private Equity (ELTA) 2,439.00p -1.45%Dechra Pharmaceuticals (DPH) 675.50p -1.39%Xaar (XAR) 1,095.00p -1.35%Evraz (EVR) 82.10p -1.20%Crest Nicholson Holdings (CRST) 375.00p -1.19%Debenhams (DEB) 74.25p -0.93%UK Commercial Property Trust (UKCM) 78.00p -0.83%Domino's Pizza Group (DOM) 543.50p -0.82%BC
More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.